These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32534358)

  • 1. A UPLC-Q-TOF/MS-based plasma metabolomics approach reveals the mechanism of Compound Kushen Injection-based intervention against non-small cell lung cancer in Lewis tumor-bearing mice.
    Wu H; Wang L; Zhan X; Wang B; Wu J; Zhou A
    Phytomedicine; 2020 Jun; 76():153259. PubMed ID: 32534358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention effect of Qi-Yu-San-Long Decoction on Lewis lung carcinoma in C57BL/6 mice: Insights from UPLC-QTOF/MS-based metabolic profiling.
    Wu H; Chen Y; Li Q; Gao Y; Zhang X; Tong J; Zhang Z; Hu J; Wang D; Zeng S; Li Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():23-33. PubMed ID: 30366209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cellular metabolomics and lipidomics to decipher the mechanism of Huachansu injection-based intervention against human hepatocellular carcinoma cells.
    Wu H; Cheng H; Luo S; Peng C; Zhou A; Chen Z; Wu H; Li Q
    J Pharm Biomed Anal; 2022 Apr; 212():114654. PubMed ID: 35158184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the anti-mitochondrial apoptosis mechanism of Erigeron breviscapus injection based on UPLC-Q-TOF-MS metabolomics and molecular docking in rats with cerebral ischemia-reperfusion injury.
    Zhang J; Han M; Wang S; Wu R; Zhao Q; Chen M; Yang Y; Zhang J; Meng X; Zhang Y; Wang Z
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117310. PubMed ID: 37827296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
    Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
    Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
    Wang KX; Du GH; Qin XM; Gao L
    Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS.
    Zhu S; Han X; Yang R; Tian Y; Zhang Q; Wu Y; Dong S; Zhang B
    Chem Biol Interact; 2023 Jan; 370():110305. PubMed ID: 36529159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic study of natrin-induced apoptosis in SMMC-7721 hepatocellular carcinoma cells by ultra-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
    Lu S; Lu R; Song H; Wu J; Liu X; Zhou X; Yang J; Zhang H; Tang C; Guo H; Hu J; Mao G; Lin H; Su Z; Zheng H
    Int J Biol Macromol; 2019 Mar; 124():1264-1273. PubMed ID: 30508545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A UPLC-QTOF/MS-based hepatic tissue metabolomics approach deciphers the mechanism of Huachansu tablets-based intervention against hepatocellular carcinoma.
    Chen C; Wu H; Fu X; Li R; Cheng H; Wang M; Zhou A; Zhang M; Li Q
    J Pharm Biomed Anal; 2024 Feb; 239():115875. PubMed ID: 38061172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
    Liu X; Wu Y; Zhang Y; Bu D; Wu C; Lu S; Huang Z; Song Y; Zhao Y; Guo F; Ye P; Fu C; Shen L; Zhang J; Wang H; Duan X; Wu J
    Front Oncol; 2021; 11():747300. PubMed ID: 34604090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model.
    Gao X; Huang C; Geng T; Chen X; Wang J; Liu J; Duan K; Cao L; Wang Z; Xiao W
    J Ethnopharmacol; 2020 Mar; 250():112429. PubMed ID: 31812644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals Potential Anti-tumor Mechanism of Banxia Xiexin Decoction in Colorectal Cancer Mice.
    Yue YZ; Li MX; Wang XH; Qin YY; Wang YH; Tan JH; Su LL; Yan S
    Chin J Integr Med; 2024 Jul; 30(7):623-632. PubMed ID: 37222828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line.
    Gao D; Wang Y; Xie W; Yang T; Jiang Y; Guo Y; Guan J; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1014():17-23. PubMed ID: 26859520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolomics study of Berberidis Radix in intervening ulcerative colitis based on UPLC-Q-TOF-MS].
    Hu XL; Zhou CY; Xu R; Li H; Yang B; Long J; Tu X; Nie J; Liu KY; Hu ZH
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2490-2499. PubMed ID: 37282878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Chemical Profiles, Anti-Inflammatory Activity, and UPLC-Q-TOF/MS-Based Metabolomics in Endotoxic Fever Rats between Synthetic Borneol and Natural Borneol.
    Zou L; Zhang Y; Li W; Zhang J; Wang D; Fu J; Wang P
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28858264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolomic study on urine of chronic inflammation rats treated with Buyang Huanwu Decoction based on UPLC-Q-TOF-MS].
    You XY; Jiang L; Wang WF; Xu X; Zhang SW; Liu HN; Yan XJ; Nie P; Li BT; Xu GL
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5345-5355. PubMed ID: 38114124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell metabolomics study on the anticancer effects of
    Liu Q; Shen JM; Hong HJ; Yang Q; Liu W; Guan Z; Wang YT; Chen XJ
    Front Pharmacol; 2022; 13():1017830. PubMed ID: 36188550
    [No Abstract]   [Full Text] [Related]  

  • 19. [UPLC-Q-TOF-MS-based metabolomics reveals mechanism of Morinda officinalis iridoid glycosides in treating rheumatoid arthritis and bone loss].
    Shen Y; Sun YQ; Li HM; Zhang QL; Zhao QM; Xu JL; Qin LP; Zhang QY
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):453-460. PubMed ID: 38403321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing metabolites and potential metabolic pathways changes to understanding the mechanism of medicinal plant Phellodendri Amurensis cortex against doxorubicin-induced nephritis rats using UPLC-Q/TOF-MS metabolomics.
    Zhang H; Zhang S; Wang W; Wang Q; Kuang H; Wang Q
    J Pharm Biomed Anal; 2020 Sep; 188():113336. PubMed ID: 32653762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.